⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483235 | 0.74 | — | — | |
| SCHEMBL3205736 | 0.74 | — | — | |
| SCHEMBL8279441 | 0.74 | — | — | |
| SCHEMBL8463208 | 0.70 | ALDH1A1 (0.47) | — | |
| SCHEMBL1041578 | 0.70 | — | — | |
| Acrylamide SCHEMBL170034 | 0.70 | TSHR (1.00) | — | |
| SCHEMBL2861105 | 0.70 | — | — | |
| SCHEMBL4252954 | 0.70 | — | — | |
| Acrylamide SCHEMBL1332245 | 0.70 | — | — | |
| Acrylamide SCHEMBL3051 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 437 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4321247-A2 | POLYAMINE PHOSPHORUS DENDRIMER MATERIALS FOR METAL SEQUESTRATION | Research Triangle Institute (US) | 2024-02-14 | — | — | EP | claimed |
| EP-3911606-B1 | METHOD FOR METAL SEQUESTRATION WITH POLYAMINE PHOSPHORUS DENDRIMER MATERIALS | RES TRIANGLE INST (US) | 2023-12-27 | — | — | EP | claimed |
| CN-111662222-B | Preparation method of bismaleimide alkyl compound | 苏州昊帆生物股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-20230101316-A1 | POLYAMINE PHOSPHORUS DENDRIMER MATERIALS FOR METAL SEQUESTRATION | UNITED STATES DEPARTMENT OF ENERGY | 2023-03-30 | — | — | US | claimed |
| EP-3911606-A1 | POLYAMINE PHOSPHORUS DENDRIMER MATERIALS FOR METAL SEQUESTRATION | Research Triangle Institute (US) | 2021-11-24 | — | — | EP | claimed |
| CN-113557037-A | Radiopharmaceuticals for diagnostic/therapeutic use in nuclear medicine and radiation guided medicine | 罗马大学 | 2021-10-26 | — | — | CN | claimed |
| US-10994261-B2 | Polyamine phosphorus dendrimer materials for carbon dioxide capture | RESEARCH TRIANGLE INSTITUTE (US) | 2021-05-04 | — | — | US | claimed |
| CN-111662222-A | Preparation method of bismaleimide alkyl compound | 苏州昊帆生物股份有限公司 | 2020-09-15 | — | — | CN | claimed |
| US-20190224647-A1 | Polyamine Phosphorus Dendrimer Materials for Carbon Dioxide Capture | UNITED STATES DEPARTMENT OF ENERGY | 2019-07-25 | — | — | US | claimed |
| US-9718780-B2 | Substituted pyridines as sodium channel blockers | PURDUE PHARMA L.P. | 2017-08-01 | — | — | US | claimed |
| EP-1067174-A1 | Process for producing particles of amine reaction product | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-10 | — | — | EP | claimed |
| EP-1067173-A1 | Process for producing particles of amine reaction product | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-10 | — | — | EP | claimed |
| EP-1067117-A1 | Process for making imine compounds | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-10 | — | — | EP | claimed |
| EP-1015475-A1 | VITAMIN B 12? RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 2000-07-05 | — | — | EP | claimed |
| WO-2000002982-A2 | LAUNDRY AND CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-20 | — | — | WO | claimed |
| WO-2000002987-A2 | AMINE REACTION COMPOUNDS COMPRISING ONE OR MORE ACTIVE INGREDIENT | THE PROCTER & GAMBLE COMPANY (US) | 2000-01-20 | — | — | WO | claimed |
| WO-1997014711-A9 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | — | 1997-10-02 | — | — | WO | claimed |
| WO-1997014711-A1 | VITAMIN B12 RECEPTOR MODULATING AGENTS AND METHODS RELATED THERETO | RECEPTAGEN CORPORATION (US) | 1997-04-24 | — | — | WO | claimed |
| EP-0496195-B1 | Starch-oil treatment for glass fibers | PPG INDUSTRIES INC (US) | 1996-04-24 | — | — | EP | claimed |
| EP-0420116-A2 | Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis | MERRELL PHARMACEUTICALS INC. (US) | 1991-04-03 | — | — | EP | claimed |